Abstract 480: An engineered bacterial delivery platform, BacID, selectively delivers activated Caspase-3 into the cytoplasm of cancer cells, eliminating tumors and reducing metastatic burden
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: University of Massachusetts Amherst
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409691199
